Advertisement

Topics

Temple researchers identify novel mechanism underlying efficacy of common heart failure drug

20:00 EDT 2 Jul 2017 | AAAS

(Temple University Health System) Beta-blocker drugs serve a key role in the treatment of heart failure, preventing bombardment of the heart by catecholamines -- substances like epinephrine and norepinephrine -- which overexcite and stress the heart. But not all HF patients respond to beta-blockers, for reasons that are unclear. Now, researchers at the Lewis Katz School of Medicine at Temple University show that dysfunction of beta-adrenergic receptor 3 (β3AR) and consequent decreases in a critical cardioprotective phospholipid may be to blame.

Original Article: Temple researchers identify novel mechanism underlying efficacy of common heart failure drug

NEXT ARTICLE

More From BioPortfolio on "Temple researchers identify novel mechanism underlying efficacy of common heart failure drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Mental Health
Adhd Anorexia Depression Dyslexia Mental Health Psychiatry Schizophrenia Stress Mental health, although not being as obvious as physical health, is very important, causing great unhappiness to those affected, causing add...